MX363258B - Compuestos piridinilpirazoloquinolina. - Google Patents
Compuestos piridinilpirazoloquinolina.Info
- Publication number
- MX363258B MX363258B MX2015013446A MX2015013446A MX363258B MX 363258 B MX363258 B MX 363258B MX 2015013446 A MX2015013446 A MX 2015013446A MX 2015013446 A MX2015013446 A MX 2015013446A MX 363258 B MX363258 B MX 363258B
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- compound
- pyridinylpyrazoloquinoline
- group
- represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361809118P | 2013-04-05 | 2013-04-05 | |
| US201361809095P | 2013-04-05 | 2013-04-05 | |
| PCT/JP2014/059852 WO2014163146A1 (ja) | 2013-04-05 | 2014-04-03 | ピリジニルピラゾロキノリン化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015013446A MX2015013446A (es) | 2016-01-12 |
| MX363258B true MX363258B (es) | 2019-03-19 |
Family
ID=51658437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015013446A MX363258B (es) | 2013-04-05 | 2014-04-03 | Compuestos piridinilpirazoloquinolina. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9550776B2 (de) |
| EP (1) | EP2982674B1 (de) |
| JP (1) | JP6244353B2 (de) |
| KR (1) | KR102234131B1 (de) |
| CN (1) | CN105189496B (de) |
| AU (1) | AU2014250391B2 (de) |
| BR (1) | BR112015024075B1 (de) |
| CA (1) | CA2904820C (de) |
| CL (1) | CL2015002837A1 (de) |
| ES (1) | ES2654094T3 (de) |
| HK (1) | HK1219100A1 (de) |
| IL (1) | IL241695B (de) |
| MX (1) | MX363258B (de) |
| PE (1) | PE20151718A1 (de) |
| PH (1) | PH12015502178A1 (de) |
| RU (1) | RU2655172C2 (de) |
| SG (1) | SG11201507733YA (de) |
| TW (1) | TW201439091A (de) |
| WO (1) | WO2014163146A1 (de) |
| ZA (1) | ZA201507044B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201406486D0 (en) | 2014-04-10 | 2014-05-28 | Redx Pharma Ltd | Antibacterial compounds |
| WO2017046606A1 (en) * | 2015-09-18 | 2017-03-23 | Redx Pharma Plc | Antibacterial compounds |
| BR112019023552A2 (pt) | 2017-06-01 | 2020-06-02 | Eisai R&D Management Co., Ltd. | Agente terapêutico para a demência com corpos de lewy contendo derivado de pirazoloquinolina |
| TWI802591B (zh) | 2017-09-14 | 2023-05-21 | 日商第一三共股份有限公司 | 具有環狀構造的化合物 |
| WO2021150613A1 (en) | 2020-01-20 | 2021-07-29 | Incyte Corporation | Spiro compounds as inhibitors of kras |
| WO2021231526A1 (en) | 2020-05-13 | 2021-11-18 | Incyte Corporation | Fused pyrimidine compounds as kras inhibitors |
| US11767320B2 (en) | 2020-10-02 | 2023-09-26 | Incyte Corporation | Bicyclic dione compounds as inhibitors of KRAS |
| AU2022367432A1 (en) | 2021-10-14 | 2024-05-02 | Incyte Corporation | Quinoline compounds as inhibitors of kras |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05132484A (ja) | 1991-04-26 | 1993-05-28 | Otsuka Pharmaceut Factory Inc | ピラゾロキノリン及びピラゾロナフチリジン誘導体 |
| DE69518075T2 (de) | 1994-05-24 | 2001-03-22 | Hoffmann La Roche | Tricyclische dicarbonylderivate |
| DE102004004142A1 (de) * | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine |
| US20060035920A1 (en) | 2004-05-28 | 2006-02-16 | Millennium Pharmaceuticals, Inc. | Chk-1 inhibitors |
| JP2006045118A (ja) | 2004-08-04 | 2006-02-16 | Mochida Pharmaceut Co Ltd | 新規ピラゾロキノロン誘導体 |
| AU2006289838B2 (en) | 2005-09-15 | 2011-08-18 | Aska Pharmaceutical Co., Ltd. | Heterocyclic compound, and production process and use thereof |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
| US8299080B2 (en) | 2006-12-13 | 2012-10-30 | Aska Pharmaceutical Co., Ltd. | Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor |
| GEP20125405B (en) | 2007-05-11 | 2012-02-27 | Pfizer | Amino-heterocyclic compounds |
| UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| PL2404922T3 (pl) * | 2009-03-05 | 2017-03-31 | Astellas Pharma Inc. | Związki chinoksalinowe |
| MX2011010184A (es) | 2009-03-31 | 2011-10-28 | Boehringer Ingelheim Int | Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4 -ona y su uso como moduladores de pde9a. |
| JP5888237B2 (ja) * | 2010-09-07 | 2016-03-16 | アステラス製薬株式会社 | ピラゾロキノリン化合物 |
| PL2573073T3 (pl) | 2011-09-26 | 2015-04-30 | Sanofi Sa | Pochodne pirazolochinolinonu, ich wytwarzanie i ich zastosowanie terapeutyczne |
| JP6042060B2 (ja) | 2011-09-26 | 2016-12-14 | サノフイ | ピラゾロキノリノン誘導体、その調製および治療上の使用 |
| RU2605096C2 (ru) * | 2011-10-07 | 2016-12-20 | ЭЙСАЙ АрЭНДДи МЕНЕДЖМЕНТ КО., ЛТД. | Пиразолохинолиновое производное |
-
2014
- 2014-04-03 WO PCT/JP2014/059852 patent/WO2014163146A1/ja active Application Filing
- 2014-04-03 KR KR1020157026010A patent/KR102234131B1/ko active IP Right Grant
- 2014-04-03 EP EP14780073.4A patent/EP2982674B1/de active Active
- 2014-04-03 BR BR112015024075-5A patent/BR112015024075B1/pt active IP Right Grant
- 2014-04-03 TW TW103112618A patent/TW201439091A/zh unknown
- 2014-04-03 US US14/778,202 patent/US9550776B2/en active Active
- 2014-04-03 MX MX2015013446A patent/MX363258B/es unknown
- 2014-04-03 PE PE2015001977A patent/PE20151718A1/es not_active Application Discontinuation
- 2014-04-03 ES ES14780073.4T patent/ES2654094T3/es active Active
- 2014-04-03 CA CA2904820A patent/CA2904820C/en active Active
- 2014-04-03 JP JP2015510131A patent/JP6244353B2/ja active Active
- 2014-04-03 RU RU2015140669A patent/RU2655172C2/ru active
- 2014-04-03 CN CN201480016592.4A patent/CN105189496B/zh active Active
- 2014-04-03 SG SG11201507733YA patent/SG11201507733YA/en unknown
- 2014-04-03 AU AU2014250391A patent/AU2014250391B2/en active Active
-
2015
- 2015-09-17 IL IL241695A patent/IL241695B/en active IP Right Grant
- 2015-09-17 PH PH12015502178A patent/PH12015502178A1/en unknown
- 2015-09-22 ZA ZA2015/07044A patent/ZA201507044B/en unknown
- 2015-09-23 CL CL2015002837A patent/CL2015002837A1/es unknown
-
2016
- 2016-06-21 HK HK16107121.9A patent/HK1219100A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105189496B (zh) | 2017-03-29 |
| US20160289225A1 (en) | 2016-10-06 |
| RU2015140669A3 (de) | 2018-03-21 |
| PE20151718A1 (es) | 2015-11-22 |
| KR102234131B1 (ko) | 2021-04-01 |
| US9550776B2 (en) | 2017-01-24 |
| BR112015024075A2 (pt) | 2017-10-24 |
| RU2015140669A (ru) | 2017-05-11 |
| EP2982674A1 (de) | 2016-02-10 |
| AU2014250391B2 (en) | 2017-11-02 |
| ZA201507044B (en) | 2017-02-22 |
| SG11201507733YA (en) | 2015-10-29 |
| HK1219100A1 (zh) | 2017-03-24 |
| CA2904820C (en) | 2021-05-18 |
| EP2982674A4 (de) | 2016-08-31 |
| IL241695B (en) | 2019-06-30 |
| BR112015024075B1 (pt) | 2022-05-03 |
| WO2014163146A1 (ja) | 2014-10-09 |
| JP6244353B2 (ja) | 2017-12-06 |
| CN105189496A (zh) | 2015-12-23 |
| MX2015013446A (es) | 2016-01-12 |
| PH12015502178A1 (en) | 2016-01-25 |
| CA2904820A1 (en) | 2014-10-09 |
| CL2015002837A1 (es) | 2016-04-22 |
| EP2982674B1 (de) | 2017-10-25 |
| TW201439091A (zh) | 2014-10-16 |
| KR20150138204A (ko) | 2015-12-09 |
| AU2014250391A1 (en) | 2015-10-15 |
| ES2654094T3 (es) | 2018-02-12 |
| JPWO2014163146A1 (ja) | 2017-02-16 |
| RU2655172C2 (ru) | 2018-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501993A1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| PH12015502178A1 (en) | Pyridinylpyrazoloquinoline compound | |
| MX2013012542A (es) | Compuestos de amida y aplicacion farmaceutica para el mismo. | |
| IN2015DN01035A (de) | ||
| MX361499B (es) | Baricitinib deuterado. | |
| MY163187A (en) | Novel imidazo-oxazine compound or salt thereof | |
| UA116395C2 (uk) | ПОХІДНІ ТРИАЗОЛ[4,5-b]ПІРИМІДИНУ | |
| UA118666C2 (uk) | Похідні піразолу | |
| MX359825B (es) | Compuesto pirazol y su uso farmaceutico. | |
| PH12015500900B1 (en) | A stabilized pemetrexed formulation | |
| PH12015501588A1 (en) | Compounds and methods for treating bacterial infections | |
| AU2015211852A1 (en) | Heterocyclic sulfonamide derivative and medicine comprising same | |
| PH12015502665A1 (en) | Improvements in or relating to organic compounds | |
| MX363545B (es) | Derivados piridin-4-ilo. | |
| MX2015015755A (es) | Derivados de perhidroquinoxalina utiles como analgesicos. | |
| GB201305247D0 (en) | Amide Compounds | |
| IN2014DN10669A (de) | ||
| PH12015501146A1 (en) | Hydantoin derivative | |
| MX2015016766A (es) | Nuevos derivados de tetrazolona. | |
| IN2014DE01203A (de) | ||
| UA88023U (ru) | Соединение 1,3-бис-(2-гидроксиэтил)-урацил с потенциальными физиологическими свойствами | |
| UA87650U (uk) | Сполука 1-(1',1'-дифтор-2'-бром-2'-хлоретил)-5-метилурацил з потенційними фізіологічними властивостями | |
| UA87694U (uk) | Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид з потенційними фізіологічними властивостями | |
| UA87253U (ru) | Соединение 1-(1',1'-дифтор-2'-бром-2'-хлорэтил)-урацил с потенциальными физиологическими свойствами | |
| UA86446U (ru) | Соединение 1,1'-(2"-бром-2"-хлорэтенил)-бис-(урацил) с потенциальными физиологическими свойствами |